Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript

Merck KGaA (OTCPK:MKGAF) Q3 2024 Earnings Convention Name November 14, 2024 8:00 AM ET

Firm Members

Constantin Fest – Head of Investor Relations
Belen Lopez – Chair of Govt Board & CEO
Helene von Roeder – CFO
Peter Guenter – CEO of Healthcare Enterprise
Matthias Heinzel – CEO of Life Science Sector
Kai Beckmann – CEO of Electronics

Convention Name Members

Sachin Jain – Financial institution of America
Jo Walton – UBS
Sophia Grace – JPMorgan
James Quigley – Goldman Sachs
Charles Pitman-King – Barclays
Thibault Boutherin – Morgan Stanley
Falko Friedrichs – Deutsche Financial institution
Dylan Van Haaften – Stifel
Oliver Metzger – Oddo BHF
Rajesh Kumar – HSBC

Operator

Expensive women and gents, welcome to the Merck Investor and Analyst Convention Name on the Third Quarter 2024. As a reminder, all contributors will likely be in a listen-only mode. I’m now handing over to Constantin Fest, Head of Investor Relations, who will lead you thru the convention. Please go forward sir.

Constantin Fest

Thanks very a lot Heidi. A really heat welcome to this Merck Q3 2024 Outcomes Name. My identify is Constantin Fest, I am Head of Investor Relations right here at Merck. In the present day I am delighted to be joined by Belen Garijo, Group CEO; in addition to Helene von Roeder, Group CFO. For the Q&Part of this name, Matthias Heinzel, and Sebastián Arana, Head of Course of Options was in Germany and fast be part of on brief discover. We’re delighted to have them with us masking Course of Options questions.

Science and Lab Options and Life Science Providers will likely be coated by Belen and Helene. Additionally, becoming a member of for the Q&A of this name, we now have Peter Guenter, the CEO of Healthcare, in addition to Kai Beckmann, CEO of Electronics. We might now wish to information you thru the important thing slides of this presentation, and after that, we’ll be glad to take